Iradimed (IRMD) Other Operating Expenses (2013 - 2026)

Iradimed (IRMD) has 14 years of Other Operating Expenses data on file, last reported at $4.1 million in Q1 2026.

• Other Operating Expenses for Q1 2026 came in at $4.1 million, down 2.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $17.3 million (up 8.34% YoY), and the FY2025 annual result was $203000.0, up 5175.0% from the prior year.
• Other Operating Expenses eased to $4.1 million in Q1 2026 per IRMD's latest filing, from $4.6 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $4.6 million in Q3 2025 and troughed at $793716.0 in Q1 2023.
• A 5-year average of $3.5 million and a median of $3.7 million in 2022 frame the typical range for Other Operating Expenses.
• The sharpest annual moves came in 2023 and 2024: Other Operating Expenses tumbled 74.14% in 2023, then jumped 382.18% in 2024.
• A 5-year view of Other Operating Expenses shows it stood at $3.7 million in 2022, then declined by 9.16% to $3.3 million in 2023, then jumped by 35.68% to $4.5 million in 2024, then advanced by 1.91% to $4.6 million in 2025, then dropped by 11.98% to $4.1 million in 2026.
• Business Quant data shows IRMD's Other Operating Expenses at $4.1 million in Q1 2026, $4.6 million in Q4 2025, and $4.6 million in Q3 2025.